Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fostemsavir + OBT in HIV-1 Infected Children and Adolescents Failing cART (SHIELD)
NCT04648280Phase 2Active, not recruiting
- Sponsor
- Penta Foundation
- Start
- Jun 2022
- Primary completion
- Dec 2028
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of fostemsavir in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Penta Foundation. Started Jun 2022; status: active, not recruiting.
02
Drugs
fostemsavir
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT04648280.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04648280.